INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the "Company")
Notification of Major Shareholdings under the Disclosure and Transparency Rules
Following the disaggregation exemption notified to the FSA under the Disclosure and Transparency Rules on 17th October 2011, AXA SA and its subsidiary notifying Group entities, acting independently from their parent and from each other, no longer have any reportable holdings in International Biotechnology Trust plc on a Group aggregated basis. However, AXA Investment Managers SA has now crossed upwards the 5% threshold and has a holding of 5.61% and 3 140 368 shares on a Group disaggregated basis as an independent Group subsidiary.
Rhona Gregg
For and on behalf of
BNP Paribas Secretarial Services Limited
Company Secretary
Telephone: 0141 225 3009
18 OCTOBER 2011